Evidence map›Paper›PMID 37389646›Full record

ArticleArchives of toxicology2023

Oral nicotine pouches with an aftertaste? Part 1: screening and initial toxicological assessment of flavorings and other ingredients.

Nadja Mallock-Ohnesorg, Selina Rinaldi, Sebastian Malke, Nadine Dreiack, Elke Pieper, Peter Laux, Thomas Schulz, Ralf Zimmermann, Andreas Luch

Open access · hybridAbstract read
In one paragraph

Article in Archives of toxicology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
6.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 28 citations in OpenAlex.

  1. Pooled it
  2. Nicotine Pouch Advertising and Sales in Australia: A Qualitative Study of Younger People's Experiences.Health promotion journal of Australia : official journal of Australian Association of Health Promotion Professionals · 2026
    Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Observational
  8. Review
  9. The Potential Impact of Oral Nicotine Pouches on Public Health: A Scoping Review.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2025
    Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Nadja Mallock-Ohnesorg *Department of Chemical and Product Safety, German Federal Institute for Risk Assessment (BfR), Berlin, Germany. Nadja.Mallock@bfr.bund.de.ORCID http://orcid.org/0000-0002-7109-0766
Selina Rinaldi *Department of Chemical and Product Safety, German Federal Institute for Risk Assessment (BfR), Berlin, Germany.
Sebastian MalkeDepartment of Chemical and Product Safety, German Federal Institute for Risk Assessment (BfR), Berlin, Germany.
Nadine DreiackDepartment of Chemical and Product Safety, German Federal Institute for Risk Assessment (BfR), Berlin, Germany.
Elke PieperDepartment of Chemical and Product Safety, German Federal Institute for Risk Assessment (BfR), Berlin, Germany.
Peter LauxDepartment of Chemical and Product Safety, German Federal Institute for Risk Assessment (BfR), Berlin, Germany.
Thomas SchulzDepartment of Chemical and Product Safety, German Federal Institute for Risk Assessment (BfR), Berlin, Germany.
Ralf ZimmermannChair of Analytical Chemistry, Joint Mass Spectrometry Centre, University of Rostock, 18059, Rostock, Germany.
Andreas LuchDepartment of Chemical and Product Safety, German Federal Institute for Risk Assessment (BfR), Berlin, Germany.
Federal Institute for Risk Assessment · DEUniversity of Rostock · DE

Funding

Bundesinstitut für Risikobewertung 1322-772
6 · The paper itself

Abstract

Nicotine pouches are oral products that deliver nicotine without containing tobacco. Previous studies mainly focused on the determination of known tobacco toxicants, while yet no untargeted analysis has been published on unknown constituents, possibly contributing to toxicity. Furthermore, additives might enhance product attractiveness. We therefore performed an aroma screening with 48 different nicotine-containing and two nicotine-free pouches using gas chromatography coupled to mass spectrometry, following acidic and basic liquid-liquid extraction. For toxicological assessment of identified substances, European and international classifications for chemical and food safety were consulted. Further, ingredients listed on product packages were counted and grouped by function. Most abundant ingredients comprised sweeteners, aroma substances, humectants, fillers, and acidity regulators. 186 substances were identified. For some substances, acceptable daily intake limits set by European Food Safety Agency (EFSA) and Joint FAO/WHO Expert Committee on Food Additives are likely exceeded by moderate pouch consumption. Eight hazardous substances are classified according to the European CLP regulation. Thirteen substances were not authorized as food flavorings by EFSA, among them impurities such as myosmine and ledol. Three substances were classified by International Agency for Research on Cancer as possibly carcinogenic to humans. The two nicotine-free pouches contain pharmacologically active ingredients such as ashwagandha extract and caffeine. The presence of potentially harmful substances may point to the need for regulation of additives in nicotine-containing and nicotine-free pouches that could be based on provisions for food additives. For sure, additives may not pretend positive health effects in case the product is used.

Indexed as

Flavoring AgentsNicotineFood AdditivesGas Chromatography-Mass SpectrometryHumansFlavoring AgentsFood AdditivesNicotineAroma screeningNicotine pouchesToxicological assessmentUntargeted analysis

Identifiers

PMID37389646
PMCPMC10404176
OpenAlexW4382631874

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.